Pharma Videos

Don't Do THIS on a GLP-1? | What the Fitness | Biolayne

The video challenges a claim that artificial sweeteners trigger insulin spikes and hypoglycemia in people taking GLP‑1 medications. The host, a plastic surgeon presenting himself as a GLP‑1 expert, argues that the brain misinterprets sweeteners as sugar, prompting an insulin surge. The critique points out that GLP‑1 drugs primarily improve insulin sensitivity, allowing the body to use glucose more efficiently, not to over‑produce insulin. Multiple randomized controlled trials and meta‑analyses have consistently shown that common artificial sweeteners do not raise insulin levels, affect blood glucose, or increase appetite. The presenter’s credentials and the logic of his argument are called into question, highlighting a disconnect between anecdotal claims and peer‑reviewed evidence. Key excerpts include the erroneous claim, “Artificial sweeteners cause insulin release, making you hypoglycemic,” and the rebuttal, “numerous randomized control trials… do not increase insulin.” The video also uses sarcasm, suggesting the surgeon could use diet coke to induce fainting before procedures. The broader implication is that patients on GLP‑1 therapies need not avoid diet sodas or other low‑calorie sweeteners out of fear of low blood sugar. Dispelling such myths prevents unnecessary dietary restrictions and reduces anxiety, allowing clinicians to focus on evidence‑based guidance.